CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH ASTERISKS (***), HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AGREEMENT AND...Agreement and Plan of Merger • October 5th, 2018 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER, dated as of August 8, 2018 (this “Agreement”), among Emergent BioSolutions Inc., a corporation organized under the Laws of Delaware (“Parent”), Panama Merger Sub, Ltd., an exempted company incorporated with limited liability in the Cayman Islands and a wholly-owned indirect Subsidiary of Parent (“Merger Sub”), PaxVax Holding Company Ltd., an exempted company incorporated with limited liability in the Cayman Islands (the “Company”), and PaxVax SH Representative LLC, a limited liability company organized under the Laws of the Cayman Islands (the “Shareholder Representative”).
